Soleno Therapeutics
SLNO
SLNO was delisted on the 15th of May, 2026.
8 hedge funds and large institutions have $1.24M invested in Soleno Therapeutics in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
60% more funds holding
Funds holding: 5 → 8 (+3)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
53% less capital invested
Capital invested by funds: $2.62M → $1.24M (-$1.39M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$111K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$71.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$53.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.15K |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$1.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$109K |
| 2 |
Citigroup
New York
|
-$4.23K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$768 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BG
1
Bollard Group
Boston,
Massachusetts
| $1M | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $157K | +$111K | +289 | +64% |
|
|
VKH
3
Virtu KCG Holdings
New York
| $39K | +$71.1K | +185 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $30K | +$53.8K | +140 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $3K | +$6.15K | +16 | New |
|
|
6
Citigroup
New York
| $1K | -$4.23K | -11 | -73% |
|
|
BIM
7
BlackRock Investment Management
Wilmington,
Delaware
| $1K | +$1.54K | +4 | New |
|
|
8
Jane Street
New York
| – | -$109K | -227 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$768 | -2 | -67% |
|
SLNO Hedge Fund Activity: Q2 2015 in Review
8 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics (SLNO) for Q2 2015, worth a combined $1.24M — down 53% from $2.62M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SLNO positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $111K. The largest seller was Jane Street, exiting entirely with an estimated $109K sold.
- 8 institutional investors held Soleno Therapeutics (SLNO) as of Q2 2015, up from 5 in Q1 2015.
- Funds reported $1.24M of Soleno Therapeutics stock for Q2 2015, down 53% quarter-over-quarter.
- 4 funds opened new Soleno Therapeutics positions in Q2 2015 and 1 closed out, a net change of +3 holders.
- The largest Soleno Therapeutics buyer in Q2 2015 was Vanguard Group, an estimated $111K added.
- The largest Soleno Therapeutics seller in Q2 2015 was Jane Street, an estimated $109K sold.
Based on aggregated 13F filings for Q2 2015.